Twist Bioscience (FRA:0ME) COGS-to-Revenue : 0.59 (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Twist Bioscience COGS-to-Revenue?

Twist Bioscience's Cost of Goods Sold for the three months ended in Mar. 2024 was €40.9 Mil. Its Revenue for the three months ended in Mar. 2024 was €69.3 Mil.

Twist Bioscience's COGS to Revenue for the three months ended in Mar. 2024 was 0.59.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Twist Bioscience's Gross Margin % for the three months ended in Mar. 2024 was 41.01%.

Twist Bioscience COGS-to-Revenue Historical Data

The historical data trend for Twist Bioscience's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Twist Bioscience COGS-to-Revenue Chart

Twist Bioscience Annual Data

Trend

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

COGS-to-Revenue

Get a 7-Day Free Trial

0.87

0.68

0.61

0.59

0.63

Twist Bioscience Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.69	0.66	0.63	0.59	0.59

Twist Bioscience COGS-to-Revenue Calculation

Twist Bioscience's COGS to Revenue for the fiscal year that ended in Sep. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	145.591	/	229.667
	=	0.63

Twist Bioscience's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	40.867	/	69.278
	=	0.59

Twist Bioscience (FRA:0ME) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Twist Bioscience's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	40.867 / 69.278
	=	41.01 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Twist Bioscience COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Twist Bioscience's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Twist Bioscience (FRA:0ME) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Twist Bioscience Corp (FRA:0ME) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

TWST:USA 0ME:Germany

Address

681 Gateway Boulevard, South San Francisco, CA, USA, 94080

Website

https://www.twistbioscience.com

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of its revenue from the United States.

Twist Bioscience (FRA:0ME) Headlines

No Headlines